Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Clinical Site Personnel Survey Reports Overwhelming Preference for ScienceMedia's Protocol Compliance Management Solution Over Traditional PowerPoint


SAN DIEGO, Jan. 21, 2022 /PRNewswire/ -- A recent clinical staff survey of ScienceMedia's protocol compliance management solution, SMi Trialtm, reported 78% of survey site personnel strongly agree that they prefer SMi Trial over traditional PowerPoint for protocol-specific training.   

78% of site personnel strongly agreed or agreed they prefer SMi Trial over traditional PowerPoint.

The sponsor of a 400+ site Phase 3 trial, run in over 36 countries, originally chose SMi Trial to yield strong site engagement by providing easy access to engaging multimedia training materials focused on the highest risk areas of the study, plus a central repository of vendor materials. SMi Trial's proven compliance management platform assigned training materials by country and role, while providing traceable regulatory compliance. One year into the clinical trial, site personnel viewed SMi Trial pages well over 100,000 times per month, translating to 40 views per user per month and over 1,000,000 views in a year.

Upon surveying site personnel on their experience with SMi Trial, ScienceMedia reported three critical findings: When asked if SMi Trial's training provided a clear explanation of key points and how to avoid potential risks, 91% of site personnel strongly agreed or agreed; 80% were completely or very satisfied with the training provided by SMi Trial; and most strikingly, 78% of site personnel strongly agreed or agreed they prefer SMi Trial over traditional PowerPoint when receiving protocol-specific training.   

"Again, proof that clinical sites prefer protocol compliance management from ScienceMedia over dull, traditional PowerPoint! Even though sites were up against COVID challenges throughout 2021, 1,000,000 page views demonstrate how the right protocol-specific training solution can effectively drive site engagement for clinical studies," states ScienceMedia CEO, Mark Surles.

Surles continues, "These positive survey findings help further SMi Trial's position as a proven protocol compliance management solution?we couldn't be more thrilled to begin 2022 on such a high note."

For additional information about how our protocol compliance management platform can benefit studies, follow ScienceMedia via LinkedIn or our blog

About ScienceMedia 
ScienceMedia improves clinical competency through innovative multimedia learning solutions. SMi Trialtm, for site-based trials, and SMi TrialDtm, for decentralized or hybrid trials, are protocol compliance management platforms that mitigate clinical risk and decrease trial cost. SMi Sourcetm provides just-in-time, thoroughly referenced information on diseases and clinical trial topics through a mobile-enabled, cloud-based medical science library with 16,000+ microlearning topics and 400+ full courses.

Contact:
Jen Pfau
[email protected] 
(805) 452-1795

SOURCE ScienceMedia


These press releases may also interest you

at 18:45
IANS Research, the leading provider of independent research and advisory services for the information security industry, has announced a new strategic investment from the Apax Digital Fund II (the "Apax Digital Funds"). IANS is a widely recognized...

at 18:45
Monster Energy Releases Nine-Minute Video Showcasing Professional Snowboarders Ståle Sandbech, Torgeir Bergrem, and Rene Rinnekangas Riding Beneath the Northern Lights in the Backcountry of Norway "We had this vision or this idea to...

at 18:37
The University of Maryland's Robert H. Smith School of Business has launched the Center for Artificial Intelligence in Business to conduct research and outreach in order to realize the potential of AI through intentional design and governance...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:50
Cantaloupe, Inc. , a leading provider of end-to-end technology solutions for self-service commerce, today announced that management will host a webcast to discuss its financial results for the third quarter of fiscal year 2024 on Thursday, May 9,...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...



News published on and distributed by: